IF by specialty › Hematology
Journal of Hematology & Oncology — Impact Factor
The 2025 Impact Factor of Journal of Hematology & Oncology is 47.8 (Q1 in Hematology; fully open access).
- Impact Factor
- 47.8 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- Springer Nature (BMC)
- Open access
- fully open access
- IF source
- link.springer.com
Position within the field
Ranked 1 of the 38 journals in Hematology on this site (top 10%).
Hematology journals with a similar Impact Factor
- Blood IF 23.9
- The Lancet Haematology IF 20.4
- Circulation Research IF 18.0
- Experimental Hematology & Oncology IF 17.5
- Blood Cancer Journal IF 13.8
- Blood Cancer Discovery IF 12.2
About this value
The Journal Impact Factor of Journal of Hematology & Oncology (JCR 2025, released June 2026) is 47.8. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.